ON THE FIRST IMPLEMENTATION DAY OF THE NEW NATIONAL REIMBURSEMENT DRUG LIST, HANSOH PHARMA'S XINYUE FOR THE RARE DISEASE NMOSD WAS PRESCRIBED FOR THE FIRST TIME AS A REIMBURSABLE DRUG ACROSS CHINA
On March 1, 2023, the National Reimbursement Drug List for Basic Medical Insurance, Work-Related Injury Insurance and Maternity Insurance (2022) was o...
2023.03.01
